Richard Iles

SLP: A Zero-Contact Non-Invasive Method for Pulmonary Function Testing

Structured Light Plethysmography (SLP) is a novel non-invasive method that uses structured light to perform pulmonary function testing that does not require physical contact with a patient. The technique produces an estimate of chest wall volume changes over time. A patient is observed continuously by two cameras and a known pattern of light (i.e. structured light) is projected onto the chest using an off-the-shelf projector. Corner features from the projected light pattern are extracted, tracked and brought into correspondence for both camera views over successive frames. A novel self calibration algorithm recovers the intrinsic and extrinsic camera parameters from these point correspondences. This information is used to reconstruct a surface approximation of the chest wall and several novel ideas for ‘cleaning up’ the reconstruction are used. The resulting volume and derived statistics (e.g. FVC, FEV) agree very well with data taken with a spirometer.

Thirty-years of screening for cystic fibrosis in East Anglia

Background Newborn screening for cystic fibrosis (CF) relies on the measurement of immunoreactive trypsinogen (IRT) originating from the pancreas. The Norfolk, Suffolk and Cambridgeshire screening programme initially exploited the persistent increase in IRT seen in CF (IRT-IRT protocol) and later changed to include mutation analysis as a second tier test (IRT-DNA-IRT protocol). Results During a 30 year period 582 966 babies have been screened by IRT-IRT and 147 764 by IRT-DNA-IRT (total 730730), resulting in 296 screen positive cases of CF and 29 false negatives (including 10 false negatives with meconium ileus). Ten missed CF cases were pancreatic insufficient, however all were diagnosed before their first birthday, suggesting that a false negative result did not forestall appropriate clinical investigation. The IRT-DNA-IRT protocol had a much improved positive predictive value (PPV) of 85.9% compared to 67.3% for IRT-IRT, excluding CF babies with meconium ileus. The PPVs increased to 82.2% and 98.2% respectively if only well, term babies were considered. The main factor to account for this improvement in PPV has probably been the incorporation of DNA analysis in the second tier testing. Conclusions The diagnosis of screen-positive babies proved difficult in a minority of cases with the classification of some patients changing with evolving phenotype. Our results illustrate the importance of collecting outcome data over a long time period for accurate assessment of the screening programme. This study provides evidence that newborn screening for CF is a valid undertaking that detects 95% of unsuspected CF cases presenting before 3 years of age.

Evaluation of the agreement of tidal breathing parameters measured simultaneously using pneumotachography and structured light plethysmography

Structured light plethysmography (SLP) is a noncontact, noninvasive, respiratory measurement technique, which uses a structured pattern of light and two cameras to track displacement of the thoraco–abdominal wall during tidal breathing. The primary objective of this study was to examine agreement between tidal breathing parameters measured simultaneously for 45 sec using pneumotachography and SLP in a group of 20 participants with a range of respiratory patterns (“primary cohort”). To examine repeatability of the agreement, an additional 21 healthy subjects (“repeatability cohort”) were measured twice during resting breathing and once during increased respiratory rate (RR). Breath‐by‐breath and averaged RR, inspiratory time (tI), expiratory time (tE), total breath time (tTot), tI/tE, tI/tTot, and IE50 (inspiratory to expiratory flow measured at 50% of tidal volume) were calculated. Bland–Altman plots were used to assess the agreement. In the primary cohort, breath‐by‐breath agreement for RR was ±1.44 breaths per minute (brpm). tI, tE, and tTot agreed to ±0.22, ±0.29, and ±0.32 sec, respectively, and tI/tE, tI/tTot, and IE50/IE50SLP to ±0.16, ±0.05, and ±0.55, respectively. When averaged, agreement for RR was ±0.19 brpm. tI, tE, and tTot were within ±0.16, ±0.16, and ±0.07 sec, respectively, and tI/tE, tI/tTot, and IE50 were within ±0.09, ±0.03, and ±0.25, respectively. A comparison of resting breathing demonstrated that breath‐by‐breath and averaged agreements for all seven parameters were repeatable (P > 0.05). With increased RR, agreement improved for tI, tE, and tTot (P ≤ 0.01), did not differ for tI/tE, tI/tTot, and IE50 (P > 0.05) and reduced for breath‐by‐breath (P < 0.05) but not averaged RR (P > 0.05).

Tidal breathing patterns derived from structured light plethysmography in COPD patients compared with healthy subjects

Purpose Differences in tidal breathing patterns have been reported between patients with chronic obstructive pulmonary disease (COPD) and healthy individuals using traditional measurement techniques. This feasibility study examined whether structured light plethysmography (SLP) – a noncontact, light-based technique – could also detect differences in tidal breathing patterns between patients with COPD and healthy subjects. Patients and methods A 5 min period of tidal (quiet) breathing was recorded in each patient with COPD (n=31) and each healthy subject (n=31), matched for age, body mass index, and sex. For every participant, the median and interquartile range (IQR; denoting within-subject variability) of 12 tidal breathing parameters were calculated. Individual data were then combined by cohort and summarized by its median and IQR. Results After correction for multiple comparisons, inspiratory time (median tI) and its variability (IQR of tI) were lower in patients with COPD (p<0.001 and p<0.01, respectively) as were ratios derived from tI (tI/tE and tI/tTot, both p<0.01) and their variability (p<0.01 and p<0.05, respectively). IE50SLP (the ratio of inspiratory to expiratory flow at 50% tidal volume calculated from the SLP signal) was higher (p<0.001) in COPD while SLP-derived time to reach peak tidal expiratory flow over expiratory time (median tPTEFSLP/tE) was shorter (p<0.01) and considerably less variable (p<0.001). Thoraco–abdominal asynchrony was increased (p<0.05) in COPD. Conclusion These early observations suggest that, like traditional techniques, SLP is able to detect different breathing patterns in COPD patients compared with subjects with no respiratory disease. This provides support for further investigation into the potential uses of SLP in assessing clinical conditions and interventions.

Tidal breathing parameters measured using structured light plethysmography in healthy children and those with asthma before and after bronchodilator

Structured light plethysmography (SLP) is a light‐based, noncontact technique that measures tidal breathing by monitoring displacements of the thoracoabdominal (TA) wall. We used SLP to measure tidal breathing parameters and their within‐subject variability (v) in 30 children aged 7–16 years with asthma and abnormal spirometry (forced expiratory volume in 1 sec [FEV1] <80% predicted) during a routine clinic appointment. As part of standard care, the reversibility of airway obstruction was assessed by repeating spirometry after administration of an inhaled bronchodilator. In this study, SLP was performed before and after bronchodilator administration, and also once in 41 age‐matched controls. In the asthma group, there was a significant increase in spirometry‐assessed mean FEV1 after administration of bronchodilator. Of all measured tidal breathing parameters, the most informative was the inspiratory to expiratory TA displacement ratio (IE50SLP, calculated as TIF50SLP/TEF50SLP, where TIF50SLP is tidal inspiratory TA displacement rate at 50% of inspiratory displacement and TEF50SLP is tidal expiratory TA displacement rate at 50% of expiratory displacement). Median (m) IE50SLP and its variability (vIE50SLP) were both higher in children with asthma (prebronchodilator) compared with healthy children (mIE50SLP: 1.53 vs. 1.22, P < 0.001; vIE50SLP: 0.63 vs. 0.47, P < 0.001). After administration of bronchodilators to the asthma group, mIE50SLP decreased from 1.53 to 1.45 (P = 0.01) and vIE50SLP decreased from 0.63 to 0.60 (P = 0.04). SLP‐measured tidal breathing parameters could differentiate between children with and without asthma and indicate a response to bronchodilator.

Tidal breathing parameters measured by structured light plethysmography in children aged 2–12 years recovering from acute asthma/wheeze compared with healthy children

Measurement of lung function can be difficult in young children. Structured light plethysmography (SLP) is a novel, noncontact method of measuring tidal breathing that monitors displacement of the thoraco–abdominal wall. SLP was used to compare breathing in children recovering from an acute exacerbation of asthma/wheeze and an age‐matched cohort of controls. Children aged 2–12 years with acute asthma/wheeze (n = 39) underwent two 5‐min SLP assessments, one before bronchodilator treatment and one after. SLP was performed once in controls (n = 54). Nonparametric comparisons of patients to healthy children and of pre‐bronchodilator to post‐bronchodilator were made for all children, and also stratified by age group (2–5 vs. 6–12 years old). In the asthma/wheeze group, IE50SLP (inspiratory to expiratory flow ratio) was higher (median 1.47 vs. 1.31; P = 0.002), thoraco–abdominal asynchrony (TAA) and left–right asynchrony were greater (both P < 0.001), and respiratory rate was faster (P < 0.001) than in controls. All other timing indices were shorter and displayed reduced variability (all P < 0.001). Variability in time to peak inspiratory flow was also reduced (P < 0.001). Younger children showed a greater effect than older children for TAA (interaction P < 0.05). After bronchodilator treatment, the overall cohort showed a reduction in within‐subject variability in time to peak expiratory flow only (P < 0.001). Younger children exhibited a reduction in relative contribution of the thorax, TAA, and variability in TAA (interaction P < 0.05). SLP can be successfully performed in young children. The potential of SLP to monitor diseases such as asthma in children is worthy of further investigation. ClinicalTrials.gov identifier: NCT02543333.

Spirometric and structured light plethysmography derived measures of airflow obstruction in asthma

Introduction: Accurate diagnosis and monitoring of respiratory disease are important for breathing assessment. Conventional lung function techniques such as spirometry are challenging in young children, requiring their full cooperation. Structured Light Plethysmography (SLP) derives tidal breathing measures from thoraco-abdominal (TA) displacement in a non-contact environment. We have shown that IE50 SLP (ratio of inspiratory to expiratory TA displacement rate at 50% of TA displacement) measured by SLP is greater in asthmatic children with airflow obstruction than in healthy children (Hmeidi, H. et al., American Thoracic Society conf. proc. 2016; p10749). Aims: To examine the relationship between SLP-derived breathing parameters and parameters measured using conventional spirometry in children with asthma. Methods: Thirty stable asthmatic children (13 female, 7-16 years), with an FEV1% of SLP and FEV1% was examined using Spearman9s Rho test. Results: A correlation of -0.49 was found betweenIE50 SLP and FEV1% (p=0.005). Conclusion: We have shown that SLP can obtain objective measures of tidal breathing in children with asthma, and that IE50 SLP correlates well with FEV1% measured using spirometry. This novel parameter could be used to quantify the degree of airway obstruction.

Shortfalls in basic paediatric asthma education in healthcare professionals

We conducted an anonymised Survey Monkey asking healthcare professionals in East of England questions relating to asthma management. Fifty-four respondents included seven consultant paediatricians, 13 general practice trainees, 26 paediatric trainees and seven nurse practitioners and foundation trainees. We report a lack of knowledge, and conclude that if the National Review of Asthma Deaths (NRAD)1 recommendations are to be achieved, there is an urgent need for basic asthma education. Questions included: ‘Do infants not respond to β2 agonists because they do not have β2 receptors?’, …

IS-016 Asthma Deaths

The UK has the highest Paediatric asthma mortality and morbidity in Western Europe. Data will be reported from a longstanding regional (East of England), and the National Review into Asthma Deaths (NRAD). These data clearly describe the risk factors in the UK for asthma death in childhood. Conversely and arguably the UK produces some of the best evidence based clinical guidance (BTS /SIGN, NICE) in the world, however it is clearly failing to deliver quality and safe care to its asthma populations. This contrast has initiated an NHS England quality improvement program; “Delivering improvements in childhood asthma outcomes; A collaborative approach”, to implement a national high impact change model to improve asthma outcomes for children and young people, using the skills, expertise and resources of the 12 NHS England Strategic Clinical Networks. This aims to nationally improve the education of health workers and the asthma population at large, encourage self-management, standardise materials, and review the commissioning of asthma services. Lastly, in a financially challenged health care economy, are such ideals achievable? Pulmonology Symposium (Supported by and Unrestricted Educational Grant from Chiesi).